Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia
Clinical trial NCT03979014 · COMPLETED
Trial details
- NCT number
- NCT03979014
- Sponsor
- Imperial College London
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2025-09-05
- Enrollment
- 1099
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.